Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
NCT07775495 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2026-08-20
Summary
The goal of this observational study is to evaluate the feasibility and usability of at-home urine sample collection, preparation, and smartphone imaging using the EcoExposure™ platform in adults. The main questions it aims to answer are:
Can participants successfully collect, prepare, and photograph urine samples at home and upload the images using a smartphone app? How consistent is image quality and participant adherence across repeated sampling over approximately 12 weeks? What is the short-term day-to-day variability in optical signals during an intensive daily sampling period?
Participants will:
Complete electronic consent and a brief intake questionnaire Collect and prepare urine samples at home at scheduled timepoints Capture guided smartphone photographs of the prepared samples Upload the images and provide brief feedback through the TrialKit app Optionally add a small reference solution (spike sample) to one sample for technical evaluation only
The study is fully remote and lasts approximately 12 weeks. It is intended for product development and workflow validation purposes only and does not involve any diagnostic or clinical decision-making.
Conditions
- Healthy Adult Participants
Sponsors & Collaborators
-
Ecotera Health LLC
lead INDUSTRY
Principal Investigators
-
Melinda B. Chu, M.D. M.B.A. · Ecotera Health LLC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-08-21
- Primary Completion
- 2026-12-31
- Completion
- 2027-01-31
Countries
- United States
Study Locations
More Related Trials
-
COVID-19 Vaccines and the Development of New LUTS
NCT05582525 ·Status: COMPLETED
-
Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 ·Status: UNKNOWN
-
Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
NCT03602508 ·Status: COMPLETED
-
Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients
NCT01223937 ·Status: COMPLETED ·Phase: PHASE3
-
MIrabegron With oveRACtive bLadder Symptoms in mEn
NCT02361502 ·Status: UNKNOWN ·Phase: PHASE4
-
Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence
NCT03508648 ·Status: WITHDRAWN ·Phase: PHASE2
-
Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study
NCT03808038 ·Status: COMPLETED
-
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
NCT00477490 ·Status: COMPLETED ·Phase: PHASE3
-
Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.
NCT03175029 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
NCT01099345 ·Status: TERMINATED
-
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
NCT06797245 ·Status: RECRUITING ·Phase: NA
-
A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.
NCT01458197 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Efficacy and Safety of NDS-446 in Men With Lower Urinary Tract Symptoms (LUTS)
NCT02808013 ·Status: UNKNOWN ·Phase: PHASE2
-
Fall Prevention in Older Adults With OAB
NCT03946124 ·Status: COMPLETED ·Phase: PHASE4
-
Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria
NCT03392896 ·Status: COMPLETED ·Phase: PHASE1
-
A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder
NCT03566134 ·Status: COMPLETED ·Phase: PHASE2
-
Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder
NCT00224146 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
NCT00410514 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined Pharmacotherapy
NCT07337252 ·Status: COMPLETED
-
An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.
NCT00338624 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)
NCT02216214 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Efficacy in Women With Stress Urinary Incontinence
NCT05677295 ·Status: UNKNOWN ·Phase: PHASE3
-
A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve Trial
NCT07206446 ·Status: COMPLETED ·Phase: NA
-
Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder
NCT00479505 ·Status: COMPLETED ·Phase: PHASE2
-
Plantarflexion Reduces Urgency and Peak Detrusor Pressure in Patients With Detrusor Overactivity
NCT01837654 ·Status: COMPLETED ·Phase: NA